Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to prospectively analyze the value of 3D ultrasound perfusion
imaging for treatment planning, the prediction of therapy success, and to monitor the
treatment response in patients with a primary or metastatic liver tumor undergoing radiation
treatment.